Erythrocyte reduced glutathione level in sickle cell anaemia and glucose-6-phosphate dehydrogenase deficient Saudi subjects
A K AI-Ali Reduced glutathione (GSH) is an important constituent of erythrocytes which is involved in the protection of the red cell membrane against oxidative damage. A decrease in the GSH level enhances the formation of Heinz bodies and may contribute to increased membrane rigidity and cation leak. Glucose-6-phosphate dehydrogenase (G6PD) is responsible for the generation of nicotinamide-adenine-dinucleotide phosphate reduced form (NADPH) which is a cofactor involved in maintaining GSH in the reduced form. The pathological effects of G6PD deficiency are due to the reduced level of GSH.l In this study, conducted in the Eastern Province of Saudi Arabia, I sought to establish the level of reduced GSH in normal adults and in subjects with homozygous sickle disease (HbSS) or heterozygous sickle cell trait (HbAS), with or without G6PD deficiency.
MATERIALS AND METHODS
Blood samples were collected in ethylenediaminetetra-acetic acid (EDTA) tubes from patients attending King Fahad Teaching Hospital, Al-Qatif Central Hospital, and from volunteers attending the blood bank of the same hospitals. Haematological indices were determined for all samples using a haematology analyser (Cell DYN 700, Sequoia Turner, Moutain View, CA, USA). Cellulose acetate haemoglobin electrophoresis was performed in a Helena electrophoresis system (Helena Laboratories, Beaumont, TX, USA) using Tris-EDTA borate buffer (pH 8· 6). G6PD activity and GSH concentrations were determined spectrophotometrically." HbA 2 levels and reticulocyte counts Correspondence: Dr A K AI-Ali.
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were determined to exclude the possibility of active haemolysis, or the presence of the {1thalassemia trait. Statistical analysis was by Student's t-test and ANDVA.
RESULTS
Two hundred and seventy-five blood samples were obtained from subjects of both sexes who did not exhibit active haemolysis or {1-thalassemia trait. The mean level of GSH in normal control subjects (n = 107) was 75· 5010 of control (range 61·8-112·0%), which agrees with values reported in other populations.? The mean values of GSH in sickle cell trait (HbAS; n = 31) and HbSS (n=13) of 71·9% (range 53·2-92'2%) and 72'2% (range 64·5-85'4%), respectively, were also determined (Table I) . The difference between these levels and normal controls was not significant (P>0·05). The mean value of GSH in G6PD deficient subjects (n = 75) was 48· 4% (range 30·7-58·2%) and in groups of HbAS (n = 22) or HbSS (n = 27) with enzyme deficiency was 50'5% (range 40'4-60·7%) and 48·2% (range 43· 2-58' 0%), respectively. Statistical analysis of the latter values indicated no significant difference when compared to other groups (P>0·05). However, values of all the groups with G6PD deficiency were statistically different from those found for the groups without enzyme deficiency (P< O'05).
DISCUSSION
It is well known that the destruction of GSH precedes haemolysis of G6PD deficient red cells, and therefore leads to decreased RBC life span.' In the light of this, we developed our previous studies on the effects of G6PD deficiency on HbSS. J We found that GSH concentrations in healthy Saudi men and women were similar to those reported in other populations." The GSH level in G6PD deficient subjects of 48·4 ± 5·2070
in the present study provides clear evidence of a decreased value (P<0'05) when compared to normal. Moreover, statistical analysis of our data does not show a significant difference in GSH level between HbSS subjects with enzyme deficiency and subjects with G6PD deficiency alone. Therefore, the observation that G6PD deficient HbSS red cells survive longer than those of HbSS subjects without enzyme deficiency is not attributable to low levels of GSH. This agrees with our earlier study in which the level of glycated haemoglobin did not indicate any survival advantages when both conditions are present in the same subject. J An earlier report indicated a pathological decrease in the level of GSH in American HbSS patients." This suggests that oxidant sensitivity may play an important role in the sickling process and the development of vaso-occlusion. It is postulated that this is probably due to the inherent instability of sickle haemoglobin, which results in an increase in free radical generation in association with impaired antioxidant defence. In contrast, our data do not indicate any significant decrease in the level of GSH in Saudi
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HbSS subjects without enzyme deficiency when compared to normal controls. It is worth emphasizing that in our investigation all samples were taken from subjects who were not in sickling crisis. It has been shown that Saudi HbSS patients exhibit a benign clinical course when compared to African and American subjects with HbSS. s This has been attributed to the high fetal haemoglobin maintained by Saudi HbSS patients.
Although our results show that Saudi HbSS patients have normal levels of reduced glutathione, this may be of little clinical significance since it has been demonstrated that the NADPH level is principally responsible for protecting against oxidant damage in normal or G6PD deficient red cells."
